Phil Nadeau's Stock Ratings

TD Cowen Analyst

Phil Nadeau is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/23/2024

Overall Average Return

45.8%

Smart Score

70.7%

Overall Average Return Percentile

93rd

Number of Ratings

14
Buy NowGet Alert
07/23/2024VRTXBuy Now
Vertex Pharmaceuticals
$494.151.18%$450 → $500MaintainsBuyGet Alert
08/02/2023VRTXBuy Now
Vertex Pharmaceuticals
$494.15-25.12%$360 → $370MaintainsOutperformGet Alert
06/28/2023VRTXBuy Now
Vertex Pharmaceuticals
$494.15-27.15%$350 → $360MaintainsOutperformGet Alert
05/02/2023VRTXBuy Now
Vertex Pharmaceuticals
$494.15-29.17%$330 → $350MaintainsOutperformGet Alert
03/03/2023ELVNBuy Now
Enliven Therapeutics
$23.38Initiates → OutperformGet Alert
02/23/2023GRPHBuy Now
Graphite Bio
DowngradeOutperform → Market PerformGet Alert
02/16/2023BIIBBuy Now
Biogen
$226.2939.2%$300 → $315MaintainsOutperformGet Alert
10/28/2022VRTXBuy Now
Vertex Pharmaceuticals
$494.15-33.22%$315 → $330MaintainsOutperformGet Alert
10/24/2022PHASBuy Now
PhaseBio Pharmaceuticals
DowngradeOutperform → Market PerformGet Alert
10/24/2022TCDABuy Now
Tricida
DowngradeOutperform → Market PerformGet Alert
07/21/2022BIIBBuy Now
Biogen
$226.2919.32%$285 → $270MaintainsOutperformGet Alert
07/07/2022MLTXBuy Now
MoonLake
$44.70Initiates → OutperformGet Alert
06/13/2022VRTXBuy Now
Vertex Pharmaceuticals
$494.15-37.27%$305 → $310MaintainsOutperformGet Alert
11/23/2021AURABuy Now
Aura Biosciences
$9.54Initiates → OutperformGet Alert